medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2011, Number 2

<< Back Next >>

Rev Esp Med Quir 2011; 16 (2)

Monovalent rotavirus vaccine and mortality due to diarrhea in Mexico

Yalaupari MJP, Cruz RJL, Sil PA

Language: Spanish
References: 11
Page: 116-118
PDF size: 258.12 Kb.


ABSTRACT

The rotavirus is the most important agent cause of high morbidity and mortality in children under 2 years of age. Live-attenuated human rotavirus vaccine has an efficacy in decreasing severe diarrhea, especially in children younger than two years, in who the rotavirus has a great prevalence. The introduction of rotavirus vaccine in the national immunization program has caused an important reduction in diarrhea-related mortality rate, however, in severely malnourished infants efficacy may be diminished.


REFERENCES

  1. Parashar UD, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-306.

  2. Velásquez FR, García Lozano H, Rodríguez E, Cervantes Y, et al. Diarrhea morbidity and mortality in Mexican children impact of rotavirus disease. Pediatr Infec Dis J 2004:23:S149-S155.

  3. Ruiz-Palacios G, Pérez-Schael M, Velázquez R, Abate H, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.

  4. Sepulveda J, Bustreo F, Tapia R, Rivera J, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 2006;368:2017-2027.

  5. Braine T. Rotavirus vaccine introduction in Mexico sets precedent. Bull World Health Org 2005;83(3):167.

  6. Pan American Health Organization, World Health Organization, Albert B Sabin Vaccine Institute, Centers for Disease Control and Prevention. Proceedings of the sixth annual international rotavirus symposium, Mexico City July 2004. Washington DC: The Albert B Sabin Vaccine Institute; 2005:43.

  7. Salud en: IV Informe de gobierno. www.presidencia.gob.mx Consultado el 1 de septiembre 2010.

  8. Anuarios de Morbilidad 2000-2008. Dirección General de Epidemiología. Secretaría de Salud, México.

  9. Linhares AC, Carmo KB, Oliveira KK, Oliveira CS, et al. Nutritional status in relation to the efficacy of the rhesushuman reassortant, tetravalent rotavirus vaccines (RRV-TV) in infants from Belém, pará state, Brazil. Rev Inst Med Trop Sao Paulo 2002;44:13-16.

  10. Madhi SA, Cunliffe NA, Steele D, Witte D, et al. Effect of human rotavirus vaccine on severe diarrhea in African Infants. N Engl J Med 2010;362:289-298.

  11. Richardson V, Hernández-Pichardo J, Quintanar-Solares M, Esparza Aguilar M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010;362:299-305.




2020     |     www.medigraphic.com